Metogest

Metogest
Clinical data
ATC code	None;
Identifiers
	IUPAC name 17β-Hydroxy-16,16-dimethylestr-4-en-3-one;
CAS Number	52279-58-0 ;
PubChem CID	9839398;
ChemSpider	8015116;
UNII	BPY4IK3W14;
CompTox Dashboard (EPA)	DTXSID00200306 ;
Chemical and physical data
Formula	C20H30O2
Molar mass	302.458 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C[C@]12CC[C@H]3[C@H]([C@@H]1CC([C@@H]2O)(C)C)CCC4=CC(=O)CC[C@H]34;
	InChI InChI=1S/C20H30O2/c1-19(2)11-17-16-6-4-12-10-13(21)5-7-14(12)15(16)8-9-20(17,3)18(19)22/h10,14-18,22H,4-9,11H2,1-3H3/t14-,15+,16+,17-,18-,20-/m0/s1; Key:JYCITEUSLNKPHC-URNBORRASA-N;

Metogest (INN, USAN) (developmental code name SC-14207), also known as 16,16-dimethyl-19-nortestosterone, is a steroidal antiandrogen that was patented in 1975 and investigated as a treatment for acne but was never marketed.^[1]^[2]^[3]

References

[1]

[2]

[3]

Search

Metogest

See also

References

Clinical data

ATC code	None
Identifiers
IUPAC name 17β-Hydroxy-16,16-dimethylestr-4-en-3-one
CAS Number	52279-58-0^Y
PubChem CID	9839398
ChemSpider	8015116
UNII	BPY4IK3W14
CompTox Dashboard (EPA)	DTXSID00200306
Chemical and physical data
Formula	C₂₀H₃₀O₂
Molar mass	302.458 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES C[C@]12CC[C@H]3[C@H]([C@@H]1CC([C@@H]2O)(C)C)CCC4=CC(=O)CC[C@H]34
InChI InChI=1S/C20H30O2/c1-19(2)11-17-16-6-4-12-10-13(21)5-7-14(12)15(16)8-9-20(17,3)18(19)22/h10,14-18,22H,4-9,11H2,1-3H3/t14-,15+,16+,17-,18-,20-/m0/s1 Key:JYCITEUSLNKPHC-URNBORRASA-N